Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.

Park JM, Terabe M, Donaldson DD, Forni G, Berzofsky JA.

Cancer Immunol Immunother. 2008 Jun;57(6):907-12. Epub 2007 Nov 15.

PMID:
18004566
2.

IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.

Bree A, Schlerman FJ, Wadanoli M, Tchistiakova L, Marquette K, Tan XY, Jacobson BA, Widom A, Cook TA, Wood N, Vunnum S, Krykbaev R, Xu X, Donaldson DD, Goldman SJ, Sypek J, Kasaian MT.

J Allergy Clin Immunol. 2007 May;119(5):1251-7. Epub 2007 Mar 26.

PMID:
17379289
3.

Efficacy of IL-13 neutralization in a sheep model of experimental asthma.

Kasaian MT, Donaldson DD, Tchistiakova L, Marquette K, Tan XY, Ahmed A, Jacobson BA, Widom A, Cook TA, Xu X, Barry AB, Goldman SJ, Abraham WM.

Am J Respir Cell Mol Biol. 2007 Mar;36(3):368-76. Epub 2006 Oct 5.

PMID:
17023688
4.

Gene expression analysis in a murine model of allergic asthma reveals overlapping disease and therapy dependent pathways in the lung.

Follettie MT, Ellis DK, Donaldson DD, Hill AA, Diesl V, DeClercq C, Sypek JP, Dorner AJ, Wills-Karp M.

Pharmacogenomics J. 2006 Mar-Apr;6(2):141-52.

PMID:
16402082
5.

Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection.

McDermott JR, Humphreys NE, Forman SP, Donaldson DD, Grencis RK.

J Immunol. 2005 Sep 1;175(5):3207-13.

6.

Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.

Infect Immun. 2005 Jul;73(7):3903-11.

7.

IL-13 regulates the immune response to inhaled antigens.

Padilla J, Daley E, Chow A, Robinson K, Parthasarathi K, McKenzie AN, Tschernig T, Kurup VP, Donaldson DD, Grunig G.

J Immunol. 2005 Jun 15;174(12):8097-105.

8.

IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13.

Fish SC, Donaldson DD, Goldman SJ, Williams CM, Kasaian MT.

J Immunol. 2005 Jun 15;174(12):7716-24.

9.

IL-21 effects on human IgE production in response to IL-4 or IL-13.

Wood N, Bourque K, Donaldson DD, Collins M, Vercelli D, Goldman SJ, Kasaian MT.

Cell Immunol. 2004 Sep-Oct;231(1-2):133-45. Epub 2005 Feb 9.

PMID:
15919378
10.

Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.

Park JM, Terabe M, van den Broeke LT, Donaldson DD, Berzofsky JA.

Int J Cancer. 2005 Mar 10;114(1):80-7.

11.

RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract.

Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13596-600. Epub 2004 Aug 30.

12.

Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice?

Leigh R, Ellis R, Wattie J, Donaldson DD, Inman MD.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):851-6. Epub 2004 Jul 8.

PMID:
15242841
13.

Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivo.

Ma HL, Whitters MJ, Jacobson BA, Donaldson DD, Collins M, Dunussi-Joannopoulos K.

Int Immunol. 2004 Jul;16(7):1009-17. Epub 2004 Jun 7.

PMID:
15184346
14.

Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant.

Taube C, Wei X, Swasey CH, Joetham A, Zarini S, Lively T, Takeda K, Loader J, Miyahara N, Kodama T, Shultz LD, Donaldson DD, Hamelmann EH, Dakhama A, Gelfand EW.

J Immunol. 2004 May 15;172(10):6398-406.

15.

IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis.

Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ, Ouma JH, Mwatha JK, Jones FM, Donaldson DD, Grusby MJ, Dunne DW, Wynn TA.

Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):586-90. Epub 2003 Dec 29.

16.

Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.

Park JW, Taube C, Yang ES, Joetham A, Balhorn A, Takeda K, Miyahara N, Dakhama A, Donaldson DD, Gelfand EW.

J Allergy Clin Immunol. 2003 Dec;112(6):1078-87.

PMID:
14657862
17.

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA.

J Exp Med. 2003 Dec 1;198(11):1741-52.

18.

Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Ralpha-independent airway hyperreactivity.

Webb DC, Mahalingam S, Cai Y, Matthaei KI, Donaldson DD, Foster PS.

Eur J Immunol. 2003 Dec;33(12):3377-85.

19.

Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation.

Blaeser F, Bryce PJ, Ho N, Raman V, Dedeoglu F, Donaldson DD, Geha RS, Oettgen HC, Chatila TA.

J Exp Med. 2003 Oct 20;198(8):1189-200. Epub 2003 Oct 13.

20.

Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2.

Wood N, Whitters MJ, Jacobson BA, Witek J, Sypek JP, Kasaian M, Eppihimer MJ, Unger M, Tanaka T, Goldman SJ, Collins M, Donaldson DD, Grusby MJ.

J Exp Med. 2003 Mar 17;197(6):703-9.

21.

Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

Chiaramonte MG, Mentink-Kane M, Jacobson BA, Cheever AW, Whitters MJ, Goad ME, Wong A, Collins M, Donaldson DD, Grusby MJ, Wynn TA.

J Exp Med. 2003 Mar 17;197(6):687-701.

22.

The role of IL-13 in established allergic airway disease.

Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, Balhorn A, Donaldson DD, Dakhama A, Gelfand EW.

J Immunol. 2002 Dec 1;169(11):6482-9.

23.

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L.

Ahlers JD, Belyakov IM, Terabe M, Koka R, Donaldson DD, Thomas EK, Berzofsky JA.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13020-5. Epub 2002 Sep 13.

24.

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.

Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, Wurster AL, Donaldson DD, Collins M, Young DA, Grusby MJ.

Immunity. 2002 Apr;16(4):559-69.

25.

Roles of interleukin-13 and interferon-gamma in lung inflammation.

Grünig G, Ford JG, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VA, Warnock M, Rennick D.

Chest. 2002 Mar;121(3 Suppl):88S. No abstract available.

PMID:
11893713
26.

Effects of IL-13 on airway responses in the guinea pig.

Morse B, Sypek JP, Donaldson DD, Haley KJ, Lilly CM.

Am J Physiol Lung Cell Mol Physiol. 2002 Jan;282(1):L44-9.

27.

Critical role for IL-13 in the development of allergen-induced airway hyperreactivity.

Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT.

J Immunol. 2001 Oct 15;167(8):4668-75.

28.

Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis.

Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA.

Hepatology. 2001 Aug;34(2):273-82.

PMID:
11481612
29.

Il-13 and IFN-gamma: interactions in lung inflammation.

Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VP, Warnock M, Grünig G.

J Immunol. 2001 Aug 1;167(3):1769-77.

30.

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.

Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA.

Nat Immunol. 2000 Dec;1(6):515-20.

PMID:
11101874
31.

IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive.

Urban J, Fang H, Liu Q, Ekkens MJ, Chen SJ, Nguyen D, Mitro V, Donaldson DD, Byrd C, Peach R, Morris SC, Finkelman FD, Schopf L, Gause WC.

J Immunol. 2000 Apr 15;164(8):4250-6.

32.

Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent.

Bancroft AJ, Artis D, Donaldson DD, Sypek JP, Grencis RK.

Eur J Immunol. 2000 Jul;30(7):2083-91.

33.

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA.

J Clin Invest. 1999 Sep;104(6):777-85.

34.

The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections.

Finkelman FD, Wynn TA, Donaldson DD, Urban JF.

Curr Opin Immunol. 1999 Aug;11(4):420-6. Review.

PMID:
10448138
35.

IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs.

Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA.

J Immunol. 1999 Jan 15;162(2):920-30.

36.

Requirement for IL-13 independently of IL-4 in experimental asthma.

Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB.

Science. 1998 Dec 18;282(5397):2261-3.

37.

Interleukin-13: central mediator of allergic asthma.

Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD.

Science. 1998 Dec 18;282(5397):2258-61.

38.

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM Jr, Beier DR, Turner KJ, Wood CR, Collins M.

J Immunol. 1998 Sep 1;161(5):2317-24.

39.

IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis.

Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD.

Immunity. 1998 Feb;8(2):255-64.

40.

Progressive Schnyder's corneal dystrophy.

Ingraham HJ, Perry HD, Donnenfeld ED, Donaldson DD.

Ophthalmology. 1993 Dec;100(12):1824-7.

PMID:
8259281
41.

Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells.

Moreau JF, Donaldson DD, Bennett F, Witek-Giannotti J, Clark SC, Wong GG.

Nature. 1988 Dec 15;336(6200):690-2.

PMID:
3143918
42.

Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides.

Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D.

Nature. 1988 Dec 15;336(6200):688-90.

PMID:
3143917
43.

A modified storage protein is synthesized, processed, and degraded in the seeds of transgenic plants.

Hoffman LM, Donaldson DD, Herman EM.

Plant Mol Biol. 1988 Nov;11(6):717-29. doi: 10.1007/BF00019513.

PMID:
24272623
44.

Vectors for in vitro synthesis of poly(A)+RNA transcripts.

Hoffman LM, Donaldson DD.

Gene. 1988 Jul 15;67(1):137-40.

PMID:
2458300
45.

Synthesis and protein body deposition of maize 15-kd zein in transgenic tobacco seeds.

Hoffman LM, Donaldson DD, Bookland R, Rashka K, Herman EM.

EMBO J. 1987 Nov;6(11):3213-21.

46.
47.

The natural history of congenital sutural cataracts. Case report with long-term follow-up.

Bercovitch L, Donaldson DD.

J Pediatr Ophthalmol Strabismus. 1982 Mar-Apr;19(2):108-10.

PMID:
7097461
49.

Simultaneous stereoscopic fundus camera incorporating a single optical axis.

Donaldson DD, Prescott R, Kennedy S.

Invest Ophthalmol Vis Sci. 1980 Mar;19(3):289-97.

PMID:
7358479
50.

Stereoscopic comparator. Wtih primary use for optic discs.

Donaldson DD, Grant WM.

Arch Ophthalmol. 1978 Mar;96(3):503-4. No abstract available.

PMID:
629690

Supplemental Content

Loading ...
Support Center